Raquel Mooring 972-471-1536
FOR IMMEDIATE RELEASE
February 17, 2015
Mannatech CEO responds to recall of herbal supplements
The following is a statement from Dr. Rob Sinnott, CEO and Chief Science Officer at Mannatech, a global developer of wellness and nutritional products, regarding the recent investigation of herbal supplements in New York State. Recent headlines have herbal supplement manufacturers under fire as accusations of mislabeling and the inclusion of undisclosed ingredients in products have caused several major retailers to halt sales. (Mannatech is not part of this recall or investigation in any way.)
“I firmly believe that it is our responsibility, as well as all supplement manufacturers, to enforce rigorous quality assurance programs and to conduct close oversight of the production process from start to finish. The wellness and confidence of our customers depend on this. To that point, I would like to take this opportunity to remind our customers and their families of Mannatech’s stringent, industry-‐leading quality-‐control programs that ensure that our products are what we promise,” said Dr. Sinnott.
Mannatech’s third-‐party certification:
“Many of Mannatech’s core products undergo third-‐party certification by NSF International. NSF certification ensures that our products contain the ingredients as formulated, confirms accurate labeling and enforces purity standards. Additionally, Mannatech has a thorough and advanced quality assurance program that complies with the U.S. Food and Drug Administration’s current Good Manufacturing Practices for dietary supplements, which impact all aspects of product development, manufacturing, evaluation, storage and distribution,” said Dr. Sinnott.
“To ensure that our products deliver on their promise to support wellness, a number of Mannatech’s broad portfolio of patented products has been validated by research conducted by independent scientists and published in peer-‐reviewed scientific journals. Currently, 17 human clinical trials have been published, 13 of which were double-‐blind, placebo-‐controlled studies — the gold standard for product validation,” said Dr. Sinnott.
Do the right thing
“Along with a product substantiation Standard Operating Procedure that ensures that our claims are validated by published science, Mannatech delivers on what it promises. We stand behind every product we make and we go the extra mile to ensure that our customers and their families receive only the best products possible. We do this not because we are required to, but because it is the right thing to do,” said Dr. Sinnott.
Dr. Sinnott points out that supporting all of Mannatech’s quality assurance efforts is a money-‐ back guarantee. Mannatech stands behind the quality of its products and its customer’s satisfaction. If for any reason a customer tries a Mannatech product and is not completely satisfied, they may return it within 180 days of purchase for an exchange or refund.
For more information about Mannatech’s quality assurance program, go to: http://www.mannatechscience.org/files/file/QualityProductHandout.pdf
Individuals interested in Mannatech’s products can learn more at Mannatech.com. Those interested in obtaining technical information and reading published product studies may visit MannatechScience.org.
Mannatech, Incorporated, develops high-‐quality health, weight and fitness, and skin care products that are based on the solid foundation of nutritional science and development standards. Mannatech is dedicated to its platform of Social Entrepreneurship based on the foundation of promoting, aiding and optimizing nutrition where it is needed most around the world. Mannatech’s proprietary products are available through independent sales Associates around the globe including the United States, Canada, South Africa, Australia, New Zealand, Austria, Denmark, Germany, Norway, Sweden, the Netherlands, Spain, the United Kingdom, Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland, Czech Republic, the Republic of Korea, Mexico, Namibia and Hong Kong. For more information, visit Mannatech.com.
Please note: This release contains “forward-‐looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-‐ looking statements generally can be identified by use of phrases or terminology such as “believe,” “intend” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals or targets contained herein are also considered forward-‐looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-‐looking statements are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Mannatech’s inability to attract and retain Associates and Members, increases in competition, litigation, regulatory changes and its planned growth into new international markets. Although Mannatech believes that the expectations, statements and assumptions reflected in these forward-‐looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-‐looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-‐K and Quarterly Report on Form 10-‐Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-‐K. All of the forward-‐looking statements contained herein speak only as of the date of this release.